.Amgen has actually shared (PDF) the 1st phase 3 information on its $400 thousand eczema drug, conne...
.Biogen and UCB's depend improving in to phase 3 on the back of a failed research tries to have sett...
.Italian biotech Aptadir Therapeutics has released along with the pledge that its pipe of preclinica...
.Surge Life Sciences has fulfilled its own target in a Duchenne muscular dystrophy (DMD) research, p...
.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, occupy...
.Achilles Rehabs has torn up its own technique. The British biotech is actually quiting working on i...
.Aligos Rehabs is declaring a midstage gain in metabolic-dysfunction associated steatohepatitis (MAS...
.Basilea Pharmaceutica's work developing brand-new antifungals has obtained a significant improvemen...
.Having currently gathered up the USA legal rights to Capricor Rehabs' late-stage Duchenne muscle dy...
.After dismissing the choice date for Applied Therapeutics' metabolic condition medicine govorestat,...